期刊文献+

氨磺必利治疗首发精神分裂症的泌乳素水平与临床疗效分析 被引量:24

The effect of amisulpride on prolactin level and clinical efficacy in first-episode schizophrenic patients
原文传递
导出
摘要 目的探讨氨磺必利对首发精神分裂症患者血清泌乳素水平的影响及其与症状的关系。方法对符合DSM—IV精神分裂症诊断标准的45例患者和年龄、性别相匹配的45例健康对照,用阳性和阴性症状量表(PANSS)进行症状评定,利用酶联免疫法进行泌乳素水平测定,用配对t检验比较患者氨磺必利治疗前后血清泌乳素水平,用相关性分析研究血清泌乳素水平与症状的关系。结果首发精神分裂症患者氨磺必利治疗后血清泌乳素水平较治疗前显著升高[(12.52±8.85)ng/ml,(52.60±22.93)ng/m1,t=12.165,P〈0.001];患者治疗后血清泌乳素水平与阴性症状分减分率呈正相关(r=0.24,P〈0.05)。结论氨磺必利能引起血清泌乳素升高;血清泌乳素升高与阴性症状改善密切相关。 Objective To discuss the effect of amisulpride on the prolactin level in serum of first-episode schizophrenic patients and its relationship with symptoms. Methods 45 patients who met the DSM-IV schizo- phrenia diagnostic criteria and 45 age- and gender- matched healthy controls were assessed the clinical symptoms using positive and negative syndrome scale(PANSS) and prolactin level in serum was detected using enzymelinked immunosorbent assay. Student's t test was used to compare the prolaetin level before and after amisulpride treatment and correlation analysis was used to investigate the relationship between prolactin level in serum and symptoms with P〈0.05 were considered significantly different. Results There was significant increase in prolactin level in serum after amisulpride treatment in first-episode schizophrenic patients( (12.52±8.85) ng/ml, (52.60±22.93 ng/ml, t= 12.165, P〈0.001 ).There was a positive correlation between prolactin level in serum and reduction rate of negative symptoms( r= 0.24, P〈0.05).Conclusion Amisulpride can increase prolaetin level in serum;and the rise of serum prolactin is closely related to the improvement of negative symptoms.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2015年第1期38-41,共4页 Chinese Journal of Behavioral Medicine and Brain Science
基金 国家自然科学基金项目(81371472) 河南省卫生厅自然科学研究计划项目(200703078)
关键词 氨磺必利 精神分裂症 泌乳素 病例对照研究 Amisulpride Schizophrenia Prolactin Case control study
  • 相关文献

参考文献26

  • 1Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia [J]. Drugs, 2004,64 (20) : 2291-2314.
  • 2Kuruvilla A, Srikrishna G, Peedicayil J, et al. A study on serum pro- lactin levels in schizophrenia: Correlation with positive and negative symptoms [ J ]. Int Clin Psychopharm, 1993,8 ( 3 ) : 177-179.
  • 3Meisenzahl E, Schmitt G, GrUnder G, et al. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an io- dine-123-iodobenzamide SPET study[J]. Pharmacopsychiatry,2008, 41(5), 169-175.
  • 4韩刚亚,严冬梅,张新风.氨磺必利与利培酮治疗首发精神分裂症的随机双盲双模拟平行对照试验[J].药物流行病学杂志,2012,21(6):257-259. 被引量:50
  • 5刘林晶,刘家洪,唐伟,陈大春.氨磺必利与利培酮治疗首发精神分裂症疗效和安全性对照研究[J].中国神经精神疾病杂志,2012,38(4):249-252. 被引量:211
  • 6武建斌,李春芳.阿立哌唑与氨磺必利对女性慢性精神分裂症的糖脂代谢、泌乳素影响的对照分析[J].精神医学杂志,2013,26(2):145-146. 被引量:9
  • 7Kapur S,Zipursky R, Jones C, et al. Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia [J].Am J Psychiiat, 2000, 157(4) :514-520.
  • 8Peuskens J,Bech P, Moiler HJ, et al. Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group[ J]. Psychiatry Res, 1999,88 (2) : 107-117.
  • 9Paparrigopoulos T, Liappas J, Tzavellas E, et al. Amisulpride-induced hyperprolactinemia is reversible following discontinuation[J]. Prog Neuropsychoph, 2007,31 ( 1 ) : 92-96.
  • 10Kim EY, Kim SH, Lee NY, et al. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients withschizophrenia receiving long-term treatment with amisulpride [ J ]. Pharmacopsychiatry,2012,45(2) :57-63.

二级参考文献106

  • 1刘俊彪,吴靖华.氯丙嗪、氯氮平、利培酮对首发精神分裂症患者糖代谢、血脂和体重的影响[J].中国神经精神疾病杂志,2004,30(4):293-295. 被引量:41
  • 2陈修哲,杨晓华,陈建平,高蕊,杨晓东,郝维德.抗精神病药物对精神分裂症患者血脂、血糖和体重影响的研究[J].山东精神医学,2006,19(1):11-13. 被引量:19
  • 3[1]Schoemaker H,Claustre Y,Fage D,et al.Neurochemical character- ristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.J Pharmacol Exp Ther,1997,280(1):83
  • 4[2]Cudennec A,Fage D,Benavides J,et al.Effects of amisulpride,an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors,on integrated functional cerebral activity in the rat.Brain Rec,1997,768(1-2):257
  • 5[3]Trichard C,Paillere-Martinot ML,Attar-Levy D,et al.Binding of antipsychotic drugs to cortical 5-HT2A receptors:a PET sutdy of chlorpromazine,clozapine,and amisulpride in schizophrenic patients.Am J Psychiatry,1998,155(4):505
  • 6[4]Hamon-Vilcot B,Chaufour S,Deschamps C,et al.Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.Eur J Clin Pharmacol,1998,54(5):405
  • 7[5]Chabannes JP,Pelissolo A,Farah S,et al.Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses.Encephale,1998,24(4):386
  • 8[6]Puech A,Fleurot O,Rein W.Amisulpride,and atypical antipsychotic,in the treatment of acute episodes of schizophrenia:a dose-ranging study vs haloperidol.Acta Psychiatr Scand,1998,98(1):66
  • 9[7]Wetzel H,Grunder G,Hillert A,et al.Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology-a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist.Psychopharmacology(Berl),1998,137(3):223
  • 10[8]Rein W,Turjanski S.Clinical update on amisulpride in deficit schizophrenia.Int Clin Psychopharmacol,1997,12(Suppl)2:19

共引文献359

同被引文献166

  • 1武扬,王雷宇.非典型抗精神病药物奥氮平、利培酮与喹硫平对精神分裂症患者肝功能的影响观察[J].医学信息,2017,30(7):100-101. 被引量:10
  • 2刘启明.氨磺必利与利培酮治疗首发精神分裂症疗效和安全性对照研究[J].医学信息(医学与计算机应用),2014,0(34):264-265. 被引量:2
  • 3Ching - Cheng Chuang, Kazuyuki Nakagome, Shenghong Pu et al. Discriminant analysis of functional optical topography for schizophrenia diagnosis [J ]. Journal of biomedical optics, 2014,19(1) .011006- 1- 011006-6.
  • 4Sun J, Tang Y, Lim KO, et ah Abnormal Dynamics of EEG Oscillations in Schizophrenia Patients on Multiple Time Scales. IEEE Transactions on Biomedical Engineering, 2014, 61 (6): 1756-1764.
  • 5Chuang CC, Nakagome K, Pu SH, et al. Discriminant analysis of functional optical topography for schizophre- nia diagnosis.Journal of biomedical optics, 2014, 19 ( 1 ): 011006-1-011006-6.
  • 6A Genetically Informed, Group fMRI Connectivity Modeling Approach: Application to Schizophrenia.IEEE Transactions on Biomedical Engineering, 2014, 61 (3): 946-956.
  • 7Maglione JE, Thomas SE, Jeste DV, et al. Late-onsetschizophrenia: Do recent studies support categorizing LOS as a subtype of schizophrenia?. Current opinion in psychiatry, 2014, 27 (3): 173-178.
  • 8Luo X, Huang L, Jia P, et al. Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizo- phrenia susceptibility.Schizophrenia bulletin, 2014, 40 ( 1 ): 39-49.
  • 9Perez-Becerril C, Morris AG, Mortimer A, et al. A11elic variants in the zinc transporter-3 gene, SLC30A3, a can- didate gene identified from gene expression studies, show gender-specific association with schizophrenia. European psychiatry: the journal of the Association of European Psychia- trists, 2014, 29 (3): 172-178.
  • 10Bakken T, Kang SW, Kosonsiriluk S, et al. Differential roles of hypothalamic serotonin receptor subtypes in the regula- tion of prolactin secretion in the turkey hen.ActaHistochemica: Zeitschrift fur Histologische Topochemie, 2014, 116 ( 1 ): 131-137.

引证文献24

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部